EFFECTIVE Act

3/13/2024, 11:23 AM

Congressional Summary of S 607

Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act

This bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug (i.e., opioid medication) upon a determination that the drug does not provide a significant advantage with respect to safety or effectiveness as compared to other drugs.

Read the Full Bill

Formatted TextPDFFormatted XML

Current Status of Bill S 607

Bill S 607 is currently in the status of Bill Introduced since March 1, 2023. Bill S 607 was introduced during Congress 118 and was introduced to the Senate on March 1, 2023.  Bill S 607's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 1, 2023

Bipartisan Support of Bill S 607

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
1
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 607

Primary Policy Focus

Health

Alternate Title(s) of Bill S 607

EFFECTIVE ActEFFECTIVE ActEnsuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement ActA bill to allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.
Start holding our government accountable!

Comments

Sponsors and Cosponsors of S 607

R
Joe Manchin III
West Virginia(Democrat)
R
Mike Braun
Indiana(Republican)
R
Tammy Baldwin
Wisconsin(Democrat)

Latest Bills

To require the Board of Governors of the Federal Reserve System to conduct a study on the impact certain United States tariffs have on the cost of goods and services in the United States, and for other purposes.
Bill HR 2287April 3, 2025
Paycheck Fairness Act
Bill S 1115April 3, 2025
A resolution designating April 2025 as "Preserving and Protecting Local News Month" and recognizing the importance and significance of local news.
Bill SRES 152April 3, 2025
Common Sense Air Regulations Act
Bill HR 2288April 3, 2025
Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Motor Vehicle and Engine Pollution Control Standards; Heavy-Duty Vehicle and Engine Emission Warranty and Maintenance Provisions; Advanced Clean Trucks; Zero Emission Airport Shuttle; Zero-Emission Power Train Certification; Waiver of Preemption; Notice of Decision".
Bill HJRES 87April 3, 2025
Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Motor Vehicle and Engine and Nonroad Engine Pollution Control Standards; The 'Omnibus' Low NOX Regulation; Waiver of Preemption; Notice of Decision".
Bill HJRES 89April 3, 2025
Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Motor Vehicle and Engine Pollution Control Standards; Advanced Clean Cars II; Waiver of Preemption; Notice of Decision".
Bill HJRES 88April 3, 2025
Recognizing that the retirement of nonintermittent electric generation facilities, before facilities with equal or greater reliability attributes are available, is a threat to the reliability of the United States electric grid.
Bill HRES 290April 3, 2025
Urging the people of the United States to observe the month of March 2025 as "Bulgarian-American Heritage Month".
Bill HRES 291April 3, 2025
To improve access to evidence-based, lifesaving health care for transgender people, and for other purposes.
Bill HR 2487April 3, 2025
EFFECTIVE Act
Bill HR 1375December 15, 2023